SN..L

Smith & Nephew Plc
Smith & Nephew Plc - Director/PDMR Shareholding
30th May 2025, 12:22
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 8463K
Smith & Nephew Plc
30 May 2025
 

SMITH & NEPHEW PLC

 

30 May 2025

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

This announcement is made in accordance with the UK Market Abuse Regulation (Regulation (EU) 596/2014, as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018).

 

Reason for the notification

Initial notification /Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Smith & Nephew plc

LEI

213800ZTMDN8S67S1H61

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument

 

Smith & Nephew plc ordinary shares of USD 0.20 each

 

Identification code

ISIN: GB0009223206

Nature of the transaction

Purchase of ordinary shares through the Company's Dividend Re-Investment Plan following the 2024 final dividend payment on 28 May 2025.

Date of Transaction

2025 - 05 - 28

Place of Transaction

London Stock Exchange (XLON)

 

Name

(Position)

Director / PDMR

Price (£)

Volume

Aggregated information

Helen Barraclough

(Group General Counsel and Company Secretary)

PDMR

10.65669

803.57057

N/A Single Transaction

Craig Gaffin

(President, Global Orthopaedics)

PDMR

10.65669

331.91224

N/A Single Transaction

Paul Connolly

(President, Global Operations)

PDMR

10.65669

701.28312

N/A Single Transaction

Phil Cowdy

Chief Corporate Development & Corporate Affairs Officer

PDMR

10.65669

250.51541

N/A Single Transaction

Mizanu Kebede

(Chief Quality & Regulatory Affairs Officer)

PDMR

10.65669

553.43002

N/A Single Transaction

Deepak Nath

(Chief Executive Officer)

Director

10.65669

3,457.19103

N/A Single Transaction

Alison Parkes

(Chief Compliance Officer)

PDMR

10.65669

93.4531

N/A Single Transaction

Scott Schaffner

(President, Sports Medicine)

PDMR

10.65669

1,327.82169

N/A Single Transaction

Rohit Kashyap

(President, Advanced Wound Management and Global Commercial Operations)

PDMR

10.65669

332.8502

N/A Single Transaction

Elga Lohler

(Chief HR Officer)

PDMR

10.65669

411.65422

N/A Single Transaction

 

 

 

 

Philip Horner

Deputy Company Secretary

Smith & Nephew plc

 

Tel:  +44 (0)1923 477100

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFLFEDIIVIE]]>
TwitterFacebookLinkedIn